Skip to main content
Erschienen in: Digestive Diseases and Sciences 5/2014

01.05.2014 | Original Article

Comparison of Endoscopic Papillary Balloon Dilation and Sphincterotomy in Young Patients with CBD Stones and Gallstones

verfasst von: Yu Ri Seo, Jong Ho Moon, Hyun Jong Choi, Dong Choon Kim, Ji Su Ha, Tae Hoon Lee, Sang-Woo Cha, Young Deok Cho, Sang-Heum Park, Sun-Joo Kim

Erschienen in: Digestive Diseases and Sciences | Ausgabe 5/2014

Einloggen, um Zugang zu erhalten

Abstract

Background and Aims

Endoscopic biliary sphincterotomy (EBS) results in permanent loss of sphincter function and its long-term complications are unknown. Endoscopic papillary balloon dilation (EPBD) is an alternative procedure that preserves sphincter function, although it is associated with a higher risk of pancreatitis than is EBS. The aim of this study was to evaluate the safety and outcomes of EPBD with limited indications for removal of common bile duct (CBD) stones combined with gallstones in patients younger than 40 years.

Methods

Young (age < 40 years) patients who had CBD stones combined with gallstones on imaging studies were enrolled in this study. A total of 132 patients were randomly divided into the EPBD group (n = 62) or the EBS group (n = 70) for extraction of CBD stones. The ballooning size of EPBD ranged from 6 to 10 mm.

Results

Complete bile duct clearance was achieved in 98.4 % (61/62) of the EPBD group and 100 % (70/70) of the EBS group. Mechanical lithotripsy was required in 8.1 % (5/62) of the EPBD group and 8.6 % (6/70) of the EBS group. The early complication rates were 8.1 % (5/62) (five pancreatitis) in the EPBD group and 11.4 % (8/70) (five [7.1 %] pancreatitis, two bleeding and one perforation) in the EBS group. The recurrence rates of CBD stones were 1.6 % (1/62) in the EPBD group and 5.7 % (4/70) in the EBS group.

Conclusions

EPBD with limited indications was safe and effective as EBS for removal of CBD stones combined with gallstones in young patients who had a longer life expectancy.
Literatur
1.
Zurück zum Zitat Cotton PB. Non-operative removal of bile duct stones by duodenoscopic sphincterotomy. Br J Surg. 1980;67:1–5.PubMedCrossRef Cotton PB. Non-operative removal of bile duct stones by duodenoscopic sphincterotomy. Br J Surg. 1980;67:1–5.PubMedCrossRef
2.
Zurück zum Zitat Frossard JL, Morel PM. Detection and management of bile duct stones. Gastrointest Endosc. 2010;72:808–816.PubMedCrossRef Frossard JL, Morel PM. Detection and management of bile duct stones. Gastrointest Endosc. 2010;72:808–816.PubMedCrossRef
3.
Zurück zum Zitat Cotton PB, Lehman G, Vennes J, Geenen JE, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc. 1991;37:383–393.PubMedCrossRef Cotton PB, Lehman G, Vennes J, Geenen JE, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc. 1991;37:383–393.PubMedCrossRef
4.
Zurück zum Zitat Freeman ML, Nelson DB, Sherman S, Haber GB, et al. Complications of endoscopic biliary sphincterotomy. N Engl J Med. 1996;335:909–918.PubMedCrossRef Freeman ML, Nelson DB, Sherman S, Haber GB, et al. Complications of endoscopic biliary sphincterotomy. N Engl J Med. 1996;335:909–918.PubMedCrossRef
5.
Zurück zum Zitat Kawabe T, Komatsu Y, Tada M, Toda N, et al. Endoscopic papillary balloon dilation in cirrhotic patients: removal of common bile duct stones without sphincterotomy. Endoscopy. 1996;28:694–698.PubMedCrossRef Kawabe T, Komatsu Y, Tada M, Toda N, et al. Endoscopic papillary balloon dilation in cirrhotic patients: removal of common bile duct stones without sphincterotomy. Endoscopy. 1996;28:694–698.PubMedCrossRef
6.
Zurück zum Zitat Komatsu Y, Kawabe T, Toda N, Ohashi M, et al. Endoscopic papillary balloon dilation for the management of common bile duct stones: experience of 226 cases. Endoscopy. 1998;30:12–17.PubMedCrossRef Komatsu Y, Kawabe T, Toda N, Ohashi M, et al. Endoscopic papillary balloon dilation for the management of common bile duct stones: experience of 226 cases. Endoscopy. 1998;30:12–17.PubMedCrossRef
7.
Zurück zum Zitat Yasuda I, Tomita E, Enya M, Kato T, et al. Can endoscopic papillary balloon dilation really preserve sphincter of Oddi function? Gut. 2001;49:686–691.PubMedCentralPubMedCrossRef Yasuda I, Tomita E, Enya M, Kato T, et al. Can endoscopic papillary balloon dilation really preserve sphincter of Oddi function? Gut. 2001;49:686–691.PubMedCentralPubMedCrossRef
8.
Zurück zum Zitat Fujita N, Maguchi H, Komatsu Y, Yasuda I, et al. Endoscopic sphincterotomy and endoscopic papillary balloon dilatation for bile duct stones: a prospective randomized controlled multicenter trial. Gastrointest Endosc. 2003;57:151–155.PubMedCrossRef Fujita N, Maguchi H, Komatsu Y, Yasuda I, et al. Endoscopic sphincterotomy and endoscopic papillary balloon dilatation for bile duct stones: a prospective randomized controlled multicenter trial. Gastrointest Endosc. 2003;57:151–155.PubMedCrossRef
9.
Zurück zum Zitat Baron TH, Harewood GC. Endoscopic balloon dilation of the biliary sphincter compared to endoscopic biliary sphincterotomy for removal of common bile duct stones during ERCP: a metaanalysis of randomized, controlled trials. Am J Gastroenterol. 2004;99:1455–1460.PubMedCrossRef Baron TH, Harewood GC. Endoscopic balloon dilation of the biliary sphincter compared to endoscopic biliary sphincterotomy for removal of common bile duct stones during ERCP: a metaanalysis of randomized, controlled trials. Am J Gastroenterol. 2004;99:1455–1460.PubMedCrossRef
10.
Zurück zum Zitat Park SJ, Kim JH, Hwang JC, Kim HG, et al. Factors predictive of adverse events following endoscopic papillary large balloon dilation: results from a multicenter series. Dig Dis Sci. 2012;58:1100–1109.PubMedCrossRef Park SJ, Kim JH, Hwang JC, Kim HG, et al. Factors predictive of adverse events following endoscopic papillary large balloon dilation: results from a multicenter series. Dig Dis Sci. 2012;58:1100–1109.PubMedCrossRef
11.
Zurück zum Zitat Cetta FM. Bile infection documented as initial event in the pathogenesis of brown pigment biliary stones. Hepatology. 1986;6:482–489.PubMedCrossRef Cetta FM. Bile infection documented as initial event in the pathogenesis of brown pigment biliary stones. Hepatology. 1986;6:482–489.PubMedCrossRef
12.
Zurück zum Zitat Tazuma S. Gallstone disease: epidemiology, pathogenesis, and classification of biliary stones (common bile duct and intrahepatic). Best Pract Res Clin Gastroenterol. 2006;20:1075–1083.PubMedCrossRef Tazuma S. Gallstone disease: epidemiology, pathogenesis, and classification of biliary stones (common bile duct and intrahepatic). Best Pract Res Clin Gastroenterol. 2006;20:1075–1083.PubMedCrossRef
13.
Zurück zum Zitat Tanaka S, Sawayama T, Yoshioka T. Endoscopic papillary balloon dilation and endoscopic sphincterotomy for bile duct stones: long-term outcomes in a prospective randomized controlled trial. Gastrointest Endosc. 2004;59:614–618.PubMedCrossRef Tanaka S, Sawayama T, Yoshioka T. Endoscopic papillary balloon dilation and endoscopic sphincterotomy for bile duct stones: long-term outcomes in a prospective randomized controlled trial. Gastrointest Endosc. 2004;59:614–618.PubMedCrossRef
14.
Zurück zum Zitat Yasuda I, Fujita N, Maguchi H, Hasebe O, et al. Long-term outcomes after endoscopic sphincterotomy versus endoscopic papillary balloon dilation for bile duct stones. Gastrointest Endosc. 2010;72:1185–1191.PubMedCrossRef Yasuda I, Fujita N, Maguchi H, Hasebe O, et al. Long-term outcomes after endoscopic sphincterotomy versus endoscopic papillary balloon dilation for bile duct stones. Gastrointest Endosc. 2010;72:1185–1191.PubMedCrossRef
15.
Zurück zum Zitat Disario JA, Freeman ML, Bjorkman DJ, Macmathuna P, et al. Endoscopic balloon dilation compared with sphincterotomy for extraction of bile duct stones. Gastroenterology. 2004;127:1291–1299.PubMedCrossRef Disario JA, Freeman ML, Bjorkman DJ, Macmathuna P, et al. Endoscopic balloon dilation compared with sphincterotomy for extraction of bile duct stones. Gastroenterology. 2004;127:1291–1299.PubMedCrossRef
16.
Zurück zum Zitat Arnold JC, Benz C, Martin WR, Adamek HE, et al. Endoscopic papillary balloon dilation vs. sphincterotomy for removal of common bile duct stones: a prospective randomized pilot study. Endoscopy. 2001;33:563–567.PubMedCrossRef Arnold JC, Benz C, Martin WR, Adamek HE, et al. Endoscopic papillary balloon dilation vs. sphincterotomy for removal of common bile duct stones: a prospective randomized pilot study. Endoscopy. 2001;33:563–567.PubMedCrossRef
17.
Zurück zum Zitat Bergman JJ, Rauws EA, Fockens P, van Berkel AM, et al. Randomised trial of endoscopic balloon dilation versus endoscopic sphincterotomy for removal of bileduct stones. Lancet. 1997;349:1124–1129.PubMedCrossRef Bergman JJ, Rauws EA, Fockens P, van Berkel AM, et al. Randomised trial of endoscopic balloon dilation versus endoscopic sphincterotomy for removal of bileduct stones. Lancet. 1997;349:1124–1129.PubMedCrossRef
18.
Zurück zum Zitat Attam R, Freeman ML. Endoscopic papillary balloon dilation for stone extraction: if, when, and for how long? Gastrointest Endosc. 2010;72:1163–1166.PubMedCrossRef Attam R, Freeman ML. Endoscopic papillary balloon dilation for stone extraction: if, when, and for how long? Gastrointest Endosc. 2010;72:1163–1166.PubMedCrossRef
19.
Zurück zum Zitat Weinberg BM, Shindy W, Lo S. Endoscopic balloon sphincter dilation (sphincteroplasty) versus sphincterotomy for common bile duct stones. Cochrane Database Syst Rev. 2006;(4):CD004890. Weinberg BM, Shindy W, Lo S. Endoscopic balloon sphincter dilation (sphincteroplasty) versus sphincterotomy for common bile duct stones. Cochrane Database Syst Rev. 2006;(4):CD004890.
20.
Zurück zum Zitat Freeman ML, DiSario JA, Nelson DB, Fennerty MB, et al. Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointest Endosc. 2001;54:425–434.PubMedCrossRef Freeman ML, DiSario JA, Nelson DB, Fennerty MB, et al. Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointest Endosc. 2001;54:425–434.PubMedCrossRef
21.
Zurück zum Zitat Cheng CL, Sherman S, Watkins JL, Barnett J, et al. Risk factors for post-ERCP pancreatitis: a prospective multicenter study. Am J Gastroenterol. 2006;101:139–147.PubMedCrossRef Cheng CL, Sherman S, Watkins JL, Barnett J, et al. Risk factors for post-ERCP pancreatitis: a prospective multicenter study. Am J Gastroenterol. 2006;101:139–147.PubMedCrossRef
22.
Zurück zum Zitat Sugiyama M, Izumisato Y, Abe N, Masaki T, et al. Predictive factors for acute pancreatitis and hyperamylasemia after endoscopic papillary balloon dilation. Gastrointest Endosc. 2003;57:531–535.PubMedCrossRef Sugiyama M, Izumisato Y, Abe N, Masaki T, et al. Predictive factors for acute pancreatitis and hyperamylasemia after endoscopic papillary balloon dilation. Gastrointest Endosc. 2003;57:531–535.PubMedCrossRef
23.
Zurück zum Zitat Tsujino T, Isayama H, Komatsu Y, Ito Y, et al. Risk factors for pancreatitis in patients with common bile duct stones managed by endoscopic papillary balloon dilation. Am J Gastroenterol. 2005;100:38–42.PubMedCrossRef Tsujino T, Isayama H, Komatsu Y, Ito Y, et al. Risk factors for pancreatitis in patients with common bile duct stones managed by endoscopic papillary balloon dilation. Am J Gastroenterol. 2005;100:38–42.PubMedCrossRef
24.
Zurück zum Zitat Osanai M, Maguchi H, Takahashi K, Katanuma A, et al. Safety and long-term outcomes of endoscopic papillary balloon dilation in children with bile duct stones. Gastrointest Endosc. 2011;73:619–623.PubMedCrossRef Osanai M, Maguchi H, Takahashi K, Katanuma A, et al. Safety and long-term outcomes of endoscopic papillary balloon dilation in children with bile duct stones. Gastrointest Endosc. 2011;73:619–623.PubMedCrossRef
25.
Zurück zum Zitat Mathuna PM, White P, Clarke E, Merriman R, et al. Endoscopic balloon sphincteroplasty (papillary dilation) for bile duct stones: efficacy, safety, and follow-up in 100 patients. Gastrointest Endosc. 1995;42:468–474.PubMedCrossRef Mathuna PM, White P, Clarke E, Merriman R, et al. Endoscopic balloon sphincteroplasty (papillary dilation) for bile duct stones: efficacy, safety, and follow-up in 100 patients. Gastrointest Endosc. 1995;42:468–474.PubMedCrossRef
Metadaten
Titel
Comparison of Endoscopic Papillary Balloon Dilation and Sphincterotomy in Young Patients with CBD Stones and Gallstones
verfasst von
Yu Ri Seo
Jong Ho Moon
Hyun Jong Choi
Dong Choon Kim
Ji Su Ha
Tae Hoon Lee
Sang-Woo Cha
Young Deok Cho
Sang-Heum Park
Sun-Joo Kim
Publikationsdatum
01.05.2014
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 5/2014
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-013-2949-6

Weitere Artikel der Ausgabe 5/2014

Digestive Diseases and Sciences 5/2014 Zur Ausgabe

Stanford Multidisciplinary Seminars

Two Evils: Gastrocolic Fistula and Heart Failure

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.